- 专利标题： Methods for treating attention deficit hyperactivity disorder
-
申请号： US15284826申请日： 2016-10-04
-
公开(公告)号： US09907803B2公开(公告)日： 2018-03-06
- 发明人: Laxminarayan Bhat
- 申请人： REVIVA PHARMACEUTICALS, INC.
- 申请人地址： US CA Sunnyvale
- 专利权人： REVIVA PHARMACEUTICALS, INC.
- 当前专利权人： REVIVA PHARMACEUTICALS, INC.
- 当前专利权人地址： US CA Sunnyvale
- 代理机构： Perkins Coie LLP
- 代理商 Viola T. Kung
- 主分类号： A61K31/495
- IPC分类号： A61K31/495 ; A61K31/496 ; A61K31/535 ; A61K31/5355 ; A61K31/538
摘要：
The present invention provides a method of using arylpiperazine derivatives for treating attention deficit hyperactivity disorder (ADHD). The method comprises a step of administering to a patient in need thereof an effective amount of a compound of Formula 1, which is an arylpiperazine derivative.
公开/授权文献
信息查询
